Literature DB >> 23871638

Promotion and prevention of autoimmune disease by CD8+ T cells.

David M Gravano1, Katrina K Hoyer.   

Abstract

Until recently, little was known about the importance of CD8+ T effectors in promoting and preventing autoimmune disease development. CD8+ T cells can oppose or promote autoimmune disease through activities as suppressor cells and as cytotoxic effectors. Studies in several distinct autoimmune models and data from patient samples are beginning to establish the importance of CD8+ T cells in these diseases and to define the mechanisms by which these cells influence autoimmunity. CD8+ effectors can promote disease via dysregulated secretion of inflammatory cytokines, skewed differentiation profiles and inappropriate apoptosis induction of target cells, and work to block disease by eliminating self-reactive cells and self-antigen sources, or as regulatory T cells. Defining the often major contribution of CD8+ T cells to autoimmune disease and identifying the mechanisms by which they alter the pathogenesis of disease is a rapidly expanding area of study and will add valuable information to our understanding of the kinetics, pathology and biology of autoimmune disease. Published by Elsevier Ltd.

Entities:  

Keywords:  AIHA; ALPS; APC; Autoimmune disease; CD8+ T cell; CTL; EAE; HLA; LCMV; MBP; MHC; MOG; MPP; MS; RA; SLE; T cell receptor; T1D; TCR; TRA; Tc; Tolerance; Treg; antigen presenting cells; autoimmune hemolytic anemia; autoimmune lymphoproliferative syndrome; cytokine producing CD8+ effectors; cytotoxic T lymphocytes; experimental autoimmune encephalomyelitis; human leukocyte antigen; lymphocytic choriomeningitis virus; major histocompatibility complex; multiple sclerosis; myelin basic protein; myelin oligodendrocyte glycoprotein; myelin proteolipid protein; regulatory T cell; rheumatoid arthritis; systemic lupus erythematosus; tissue restricted antigens; type 1 diabetes

Mesh:

Year:  2013        PMID: 23871638     DOI: 10.1016/j.jaut.2013.06.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  58 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 2.  Clinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes.

Authors:  Kadri Haller-Kikkatalo; Raivo Uibo
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 3.  The role of lymphocytes in the development and treatment of alopecia areata.

Authors:  Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal:  Expert Rev Clin Immunol       Date:  2015-09-07       Impact factor: 4.473

4.  Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.

Authors:  Katalin Kis-Toth; Denis Comte; Maria P Karampetsou; Vasileios C Kyttaris; Lakshmi Kannan; Cox Terhorst; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

Review 5.  CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.

Authors:  Yixin Tan; Ming Zhao; Bo Xiang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 6.  T cells in Systemic Lupus Erythematosus.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; George C Tsokos
Journal:  Curr Opin Immunol       Date:  2016-09-13       Impact factor: 7.486

Review 7.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

8.  Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.

Authors:  Matthew B Dong; Guangchuan Wang; Ryan D Chow; Lupeng Ye; Lvyun Zhu; Xiaoyun Dai; Jonathan J Park; Hyunu R Kim; Youssef Errami; Christopher D Guzman; Xiaoyu Zhou; Krista Y Chen; Paul A Renauer; Yaying Du; Johanna Shen; Stanley Z Lam; Jingjia J Zhou; Donald R Lannin; Roy S Herbst; Sidi Chen
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

9.  Identification of a novel population of highly cytotoxic c-Met-expressing CD8+ T lymphocytes.

Authors:  Mahdia Benkhoucha; Nicolas Molnarfi; Gürkan Kaya; Elodie Belnoue; Kristbjörg Bjarnadóttir; Pierre-Yves Dietrich; Paul R Walker; Denis Martinvalet; Madiha Derouazi; Patrice H Lalive
Journal:  EMBO Rep       Date:  2017-07-27       Impact factor: 8.807

Review 10.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.